|
|
| |
 Brief Description |
| |
| This presentation at the APSARD Symposium in Philadelphia discusses Comorbidity of ADHD with Substance Abuse. Eli Lilly and Shire sponsored the filming, broadcast and archiving of the content of this symposium. MediCom offered continuing medical education with this content. |
| |
 Full Description |
| |
|
| |
 Citation |
| |
|
| |
 Abstract |
| |
|
| |
 Introduction |
| |
|
| |
 Results |
|
|
|
 Discussions |
| |
|
| |
 Material Methods |
| |
|
| |
 References |
| |
| SELECTED RECENT PUBLICATIONS BY THE AUTHOR
Faraone SV, Wilens TE. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. J Clin Psychiatry. 2007;68 Suppl 11:15-22.
Wilens TE. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. J Clin Psychiatry. 2007;68 Suppl 11:4-8.
Wilens TE, Fusillo S. When ADHD and substance use disorders intersect: relationship and treatment implications. Curr Psychiatry Rep. 2007 Oct;9(5):408-14.
Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, Ahrbecker LM, Levine LR; Atomoxetine ADHD/SUD Study Group. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008 Jul 1;96(1-2):145-54.
Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008 May;165(5):597-603. |
| |
|
|
|
Stats |
| |
| Publish date |
Views |
Ref# |
| Jan 03, 2010 |
929 |
VA:11:15:2138:2009 |
|
| |
Rating |
|
|
|
|
|
Embed Code
|
|
|
| |
Files |
| |
|
| |
| |
|